Related Experiment Video
Updated: Jul 25, 2025
05:26
A Standardized Liquid Biopsy Preanalytical Protocol for Downstream Circulating-Free DNA Applications
Published on: September 16, 2022
4.0K
Liquid Biopsy: Current Status and Future Perspectives
Vesselin Baev1, Danijela Koppers-Lalic2, Bruno Costa-Silva3
1Department of Plant Physiology and Molecular Biology, University of Plovdiv, 4000 Plovdiv, Bulgaria.
Cancers
|June 28, 2023
Summary
Biofluid analysis is crucial for cancer diagnosis and monitoring. Biomarker discovery in bodily fluids aids in understanding and managing oncological conditions effectively.
Area of Science:
- Oncology
- Biochemistry
- Medical Diagnostics
Background:
- The historical analysis of biofluids for cancer detection dates back to the Bence Jones protein discovery in the 19th century.
- Key protein biomarkers like carcinoembryonic antigen (CEA) and alpha-fetoprotein (AFP) were identified in the 1970s, highlighting biofluid utility.
- Modern advancements continue to leverage biofluid analysis for cancer management.
Discussion:
- Biofluid analysis provides a minimally invasive approach to cancer detection and monitoring.
- Biomarkers in biofluids offer insights into tumor presence, progression, and treatment response.
- The evolution of analytical techniques enhances the sensitivity and specificity of cancer biomarker detection.
Key Insights:
- The long-standing role of biofluid analysis in oncology underscores its diagnostic significance.
- Identification of specific biomarkers like CEA and AFP revolutionized cancer follow-up.
- Ongoing research focuses on novel biofluid biomarkers for earlier and more accurate cancer diagnosis.
Outlook:
- Future directions include the development of multi-analyte panels for comprehensive cancer profiling.
- Liquid biopsy technologies are poised to transform cancer diagnostics and personalized medicine.
- The integration of artificial intelligence with biofluid analysis will accelerate biomarker discovery and clinical application.
